Previous evidence also demonstrated that LATS1/LATS2 deletion in tumors, which activates YAP signaling, induced increased tumor immunogenicity, leading to tumor destruction by enhancing anti-tumor immune responses [62]. This evidence concerns the gene YAP1 and neoplasm.